Objective: Proliferation and migration of vascular smooth muscle cells (SMCs) causes intimal thickening during cardiac allograft vasculopathy (CAV). This process requires the degradation or remodeling of extracellular matrix (ECM) surrounding the cells. Imbalance between degradation and accumulation of ECM also contributes to the development of CAV. In this study, we investigated the contribution of matrix metalloprotenases (MMPs), enzymes regulating ECM turnover, to the development of CAV. Methods: Donor hearts from male DBA mice were heterotopically transplanted to male B10.D2 recipient mice, and harvested at days 15 and 30 post transplantation. We examined expression MMP-2, -3, -9 and -13 of graft vessels using immunohistochemistry. To clarify the role of MMP-2 in CAV, anti MMP-2 ribozyme was delivered into donor hearts just before transplantation, mediated by a hemagglutinating virus of Japan-liposome complex to specifically suppress MMP-2 activity. Results: All MMPs were immunopositive in SMCs from the slightly thickened neointima at day 15. In the advanced stage of intimal thickening at day 30, in addition to increased number of SMCs, accumulation of collagenous fibers was observed; expression of MMP-3, -9 and -13 was decreased. In contrast, MMP-2 expression remained distinctly positive throughout the progression of the vascular remodeling. After the gene transfer of MMP-2 ribozyme, luminal occlusion was significantly decreased compared to non-treated allografts [25.066.5 vs. 55.167.0% (P,0.05)] at day 30 post transplantation. Conclusion: MMP-2 is a principle MMP throughout the progression of the vascular remodeling in CAV. Anti MMP-2 therapy could therefore be one of the candidates for a supplemental therapy for CAV. 
1 . Introduction replication and migration of vascular smooth muscle cells (SMCs) inward to the lumen, which is stimulated by While acute rejection of transplanted hearts can be well various growth factors. However, the replication and controlled with progressive immunosuppression, chronic migration of SMCs also requires the degradation or rejection, which determines the long-term survival of remodeling of the extracellular matrix (ECM) surrounding transplant patients, remains a challenging problem.
the cells [1, 2] . Matrix metalloproteinases (MMPs) belong Chronic rejection, or cardiac allograft vasculopathy (CAV), to an endogenous family of enzymes responsible for ECM is characterized by diffuse coronary arteriopathy formed by degradation and each MMP has a specific function. The interstitial collagenase (human MMP-1, mouse MMP-13) can cleave native fibrillar collagen; type IV collagenase or gelatinase (MMP-2 and -9) degrade denatured interstitial were growth-arrested for 72 h in medium with 0.4% FBS collagen, native basement-membrane collagen and elastin.
in 100-mm plates. A 1-ml volume of each HVJ-cationicStromelysins (MMP-3) have a wide specificity against liposome was added for experiments in 100-mm plates matrix components, including gelatin, laminin, fibronectin, after removal of the medium. Cells were washed with PBS proteoglycan core proteins and elastin, and can activate the after a 2 h incubation at 37 8C, exposed to fresh medium zymogen forms of other MMPs as well [3] .
containing 0.4% FBS and stimulated by 100 ng / ml 12-OThese MMPs contribute to the pathogeneses such as tetradecanoylphorbol 13-acetate (PMA) for 24 h. ECM turnover, and cellular migration and proliferation in the neointimal formation seen after balloon injury; this 2 .2. Reverse transcriptase polymerase chain reaction pathogenesis quite resembles that of CAV. It has been (RT-PCR) shown that each MMP described above contributes differently to neointimal formation at various stages, and that SMCs were lysed with distilled water, and then total MMP-2 contributes to the increase in neointimal volume RNA was extracted by the acid guanidinium thiocyanatethroughout the progression of the intimal thickening [4] .
phenol-chloroform method. After treatment with DNase, MMP-2 is also revealed to be a principal MMP for SMC mRNA was reverse transcribed in RT solution (10 mmol / l migration [5] [6] [7] [8] . Furthermore, in our previous study, Tris-HCl, pH 8.3; 50 mmol / l KCl; 1.5 mmol / l MgCl ), 2 2 MMP-2 was shown crucially involved in the development mmol / l DTT, 50 U RNase inhibitor, and 200 U MuLV of CAV in a primate model [9] . In this study, we reverse transcriptase (Perkin-Elmer, NJ, USA) for 20 min investigated the expression of each MMP in the developat 42 8C. Primers for MMP-2, -3, -9 and -13 were ment of CAV in a murine model, and hypothesized that synthesized by Sawada Technology (Table 1 ) [11] . cDNA MMP-2 plays a crucial role, similar to that seen in was amplified using the following parameters: 94 8C, 1 neointimal formation of balloon injured arteries. We also min; 58 8C, 1 min; 72 8C, 1 min; 35 cycles. Products were delivered anti MMP-2 ribozyme to the donor hearts in analyzed by electrophoresis on 1.2% agarose gels followed order to specifically suppress MMP-2 activity, thus clarifyby ethidium bromide staining. cDNA preparations were ing the role of MMP-2 in CAV.
analyzed for GAPDH as a positive control. 85-23, revised 1996) . Donor hearts from 50 IU / ml penicillin, and 10% fetal bovine serum (FBS) at male DBA mice were heterotopically transplanted to male 37 8C and 5% CO . At confluence, approximately 4 days, B10.D2 recipient mice by microsurgical technique [12, 13] .
2 the cells were passaged by rinsing in phosphate-buffered The donor hearts were harvested at days 15 and 30 post saline (PBS), followed by a 3-min incubation at 37 8C with transplantation. Ex vivo gene transfer of anti MMP-2 0.05% trypsin and 0.02% EDTA in PBS before resuspenribozyme, DNA-ribozyme and mismatched ribozyme was sion in growth medium. All experiments were completed performed by injecting 0.1 ml of HVJ-artificial viral with cells between passages 3 and 8. Subconfluent SMCs envelope (AVE) liposome complex into the ascending aorta of the donor hearts just after harvest; hearts were then incubated 10 min on ice. The donor hearts with gene transfer were harvested at day 30 post transplantation.
.4. Histological study
The hearts were divided into two parts. One half was fixed in 10% formalin and embedded in paraffin for hematoxylin and eosin (HE), Elastica van Gieson (EvG) and Masson Trichrome staining. Degree of acute rejection was evaluated according to the working formation of the International Society for Heart and Lung Transplantation [14] . Rejection score was defined as follows: 05no cell infiltration, 15faint and limited cell infiltration, 25 moderate cell infiltration, 35severe and diffuse cell infiltration. The sections were photographed, blindly video The area encompassed by the lumen and internal elastic catalytic activity by replacing G* with A was used as a negative control. lamina (IEL) was traced and the cross sectional area of luminal stenosis (luminal occlusion) was calculated by the formula: luminal occlusion (%)5(IEL area2luminal area) / phatidylethanolamine and cholesterol was hydrated in 200 IEL area [15] .
mg of balanced salt solution (BSS) containing anti MMP-2 ribozyme, DNA-ribozyme and mismatched ribozyme ONs.
.5. Immunohistochemistry
Liposomes were prepared by shaking and sonication; in cationic liposome, DC-cholesterol was substituted for The other half of the divided hearts were stored in OCT phosphatidylserine. Purified HVJ (Z strain) was inactivated 2 compound and rapidly frozen in liquid nitrogen to be used by UV irradiation (198 mJ / cm ) just before use. The for immunohistochemical study. Serial transverse sections lipsome's suspension (0.5 ml, containing 19 mg of lipid) (6 to 8 mm) were cut, dipped in cold acetone for 10 min, was mixed with HVJ 15,000 hemagglutinating units in a and dehydrated in phosphate-buffered solution. After rehytotal volume of 1 ml BSS. The mixture was incubated at dration, sections were incubated for 12 h at 4 8C with 4 8C for 10 min and at 37 8C for 60 min with gentle primary antibodies against MMP-2 (C-19, Santa Cruz shaking. Free HVJ was removed from HVJ-liposome by Biotechnology, CA, USA), MMP-3 (C-19, Santa Cruz sucrose density gradient centrifugation. The liposomes Biotechnology), MMP-9 (C-20, Santa Cruz Biotechnolwere unilamilar, and the size of ON-containing HVJogy) and MMP-13 (Chemicon International, CA, USA) liposome complex was 400-500 nm in diameter [19] . diluted 1003, and collagen I (Southern Biotechnology Associates, AL, USA) diluted 203. Biotin-second antibody conjugate was detected with a Vector ABC kit 2 .8. Statistical analysis (Vector, Burlingame, CA, USA).
Data were expressed as mean6S.D. Differences were 2 .6. Gene transfer complex compared using analysis of variance (ANOVA). A value of P,0.05 was considered statistically significant. The sequences of ribozyme oligonucleotides (ONs) against MMP-2 mRNA are shown in Fig. 1 . The target sequence of MMP-2 is identical among mouse and rat species [16, 17] . In this study, we used DNA-based control 3 . Results ON as the negative control, because DNA ribozyme has no catalytic activity. Moreover, mismatched ribozyme from 3 .1. Efficacy and specificity of anti MMP-2 ribozyme in which catalytic activity was inactivated by replacing G* cultured SMCs with A was used as an additional negative control.
RT-PCR confirmed that MMP-2, -3, -9 and -13 were 2 .7. Preparation of HVJ-liposome expressed in cultured SMCs after stimulation by PMA. MMP-2 expression was suppressed in cultured SMCs with HVJ-AVE liposomes were prepared as described previanti MMP-2 ribozyme after stimulation, while this supously [18] . Briefly, dried lipids containing phosphatidylserpression was not observed in control ribozyme or DNA ine, phosphatidylcholin, sphingomyelin, dioleoylphosribozyme. Expression of the other MMPs was not sup- 
.2. MMP-2 is enhanced in the development of CAV
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Pathologically, neointimal formation was observed at days 15 and 30, and no significant difference was detected day 15 ( Fig. 4) . At day 30, MMP-2 expression remained among luminal occlusion ratios of non-transferred, misdistinctly positive throughout the progression of the CAV, match ribozyme transferred or DNA ribozyme transferred whereas expression of MMP-3, MMP-9 and MMP-13 was allografts. In the intramyocardium, signs of severe rejecdecreased in severely thickened neointima with increased tion (rejection score 2-3) were seen accompanied by cell number (Fig. 5A-D) . In recipient hearts, neither MMP diffuse interstitial edema, perivascular and interstitial expression, cell infiltration or intimal thickening were mononuclear cell infiltration and focal interstitial hemorobserved. rhage; no significant difference was observed in the average of this score among non-treated cardiac allografts 3 .3. Anti MMP-2 ribozyme attenuates CAV development (Table 2) . Masson Trichrom staining showed accumulation of collagenous fibers in the advanced stage in neointima Treatment with MMP-2 ribozyme ON significantly and intracellular space of media, in addition to increased suppressed intimal thickening of coronary arteries comnumber of SMCs (Fig. 3) . We performed immunostaining pared to non-treated allografts, mismatch ribozyme or for collagen type I and ensured that collagen I was DNA ribozyme treated allografts (Table 2 ). There was no expressed in the severely thickened neointima of control MMP expression in arteries of anti MMP-2 treated allogallografts (Fig. 3) . raft without intimal thickening, while unsuppressed MMPImmunohistochemically, all MMPs were enhanced in 2 expression was seen in neointima of allografts treated slightly thickened neointima of the allografts harvested at with control ONs (Fig. 5E, F) . In the intramyocardium, signs of severe rejection (rejection score 2-3) were observed and there was no significant difference in average It has been shown that collagen turnover plays an of this score between treated and non-treated cardiac important role throughout the progression of neointimal allografts.
formation after balloon injury, which pathologically resembles CAV. In addition to cell proliferation, we observed collagen accumulation in the severely thickened neointima, 4 . Discussion indicating that collagen turnover also contributes to the increase in the neointimal volume. In remodeling of the Proliferation of vascular SMCs is known to be involved vascular wall during neointimal formation after balloon in the pathogenesis of intimal thickening in the coronary injury, vascular SMCs require extracellular proteases arteriosclerosis seen in chronically rejected hearts. This has which degrade basement membrane and ECM in the been confirmed by studies suppressing luminal occlusion interstitium, allowing cell migration and proliferation [1, 2] . of the arteries by blocking cell-cycle regulating genes such MMPs are primarily involved in tumor metastasis, as as E2F [20] , PCNA [21] and cdk2 kinase [22] . The results well as in many physiological processes that are associated of these studies suggest new therapeutic methods utilizing with ECM turnover and remodeling [23, 24] . Though other gene therapy for treatment of chronic rejection of transstudies have shown that MMPs contribute to SMC migraplanted hearts, for which there is neither conventional nor tion, but not replication [8, 25, 26] , emerging data on the radical therapy at present.
role of MMPs in vascular SMC migration have suggested formation proceeded, the expression of MMP-1, -3 and -9 butes to collagen accumulation in the chronically rejected 
